Cost-effectiveness of atezolizumab plus chemotherapy for advanced non-small-cell lung cancer
Shen Lin, Shaohong Luo, Lixian Zhong, Shubin Lai, Dayong Zeng, Xin Rao, Pinfang Huang, Xiuhua Weng
Topics & Concepts
AtezolizumabCarboplatinMedicineLung cancerOncologyPaclitaxelInternal medicineQuality of life (healthcare)Cost effectivenessCancerChemotherapyCisplatinImmunotherapyPembrolizumabRisk analysis (engineering)NursingCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsEsophageal Cancer Research and Treatment